Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
- Lederman, S.
- Ottery, F.D.
- Cano, A.
- Santoro, N.
- Shapiro, M.
- Stute, P.
- Thurston, R.C.
- English, M.
- Franklin, C.
- Lee, M.
- Neal-Perry, G.
ISSN: 1474-547X, 0140-6736
Année de publication: 2023
Volumen: 401
Número: 10382
Pages: 1091-1102
Type: Article